Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorderActive, not recruitingPhase 1 / Phase 22025-10-22NCT06100276

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UniQure Biopharma B.V.5

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Barrow Neurological InstitutePhoenixUnited States50
California Pacific Medical CenterSan FranciscoUnited States9
Columbia University Irving Medical CenterNew YorkUnited States234
Massachusetts General Hospital, Sean M. Healey and AMG Center for ALS ResearchBostonUnited States1
Mayo Clinic FloridaJacksonvilleUnited States105
Mayo Clinic RochesterRochesterUnited States133
Norrlands UniversitetssjukhusUmeåSweden1
Northwestern University Feinberg School Of MedicineChicagoUnited States49
University of California IrvineIrvineUnited States30
University of Kansas Medical CenterFairwayUnited States18
University of Pennsylvania School of medicinePhiladelphiaUnited States6
Winship Cancer Institute of Emory UniversityAtlantaUnited States45